SCHEMBL7121680

SCHEMBL7121680

O=C(Nc1nc2c(Cl)cccc2s1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.61
MEN1 O00255 6/20 0.61
CASP3 P42574 1/20 0.61
SENP8 Q96LD8 1/20 0.61
SENP7 Q9BQF6 1/20 0.61
SENP6 Q9GZR1 1/20 0.61
RORC P51449 8/20 0.56
SMN1; SMN2 Q16637 5/20 0.56
MAPK1 P28482 4/20 0.56
MAPT P10636 4/20 0.56
CYP3A4 P08684 2/20 0.56
PPARG P37231 2/20 0.56
LMNA P02545 2/20 0.56
TSHR P16473 2/20 0.56
TP53 P04637 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
PKM P14618 1/20 0.56
NFKB1 P19838 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5731624 0.86 MAPT (0.69) KMT2AMEN1RORCSMN1; SMN2MAPK1
SCHEMBL7129461 0.83 DYRK1A (0.70) KMT2AMEN1SMN1; SMN2MAPK1MAPT
SCHEMBL26034887 0.81 KMT2A (0.60) KMT2AMEN1CASP3SENP8SENP7
SCHEMBL15756371 0.81 MAPK1 (0.62) KMT2AMEN1CASP3SENP8SENP7
SCHEMBL7162058 0.81 DYRK1A (0.64) KMT2AMEN1SMN1; SMN2MAPTPPARG
SCHEMBL7127487 0.80 MMP13 (0.74) KMT2AMEN1CASP3SENP8SENP7
SCHEMBL7130981 0.80 MAPT (0.62) KMT2AMEN1RORCSMN1; SMN2MAPK1
SCHEMBL7124297 0.80 DYRK1A (0.61) KMT2AMEN1RORCSMN1; SMN2MAPK1
SCHEMBL7119606 0.79 MAPT (0.61) KMT2AMEN1RORCSMN1; SMN2MAPK1
SCHEMBL23529346 0.78 KMT2A (0.64) KMT2AMEN1CASP3SENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD KMT2A 3291/4885MEN1 4865/4885CASP3 3453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.